butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers may possibly lessen sufentanil degrees and efficacy, perhaps precipitating withdrawal syndrome in people that have designed Actual physical dependence to sufentanil. Discontinu